Mode
Text Size
Log in / Sign up
N/A N=3,004 Randomized Treatment

Pragmatic Airway Resuscitation Trial

Cardiac Arrest

Enrolled (actual)
3,004
Serious AEs
0.0%
Results posted
Dec 2018
Primary outcome: Primary: Number of Patients Alive at 72 Hours After Episode. — 230; 275 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Endotracheal Intubation (Device); Laryngeal Tube (King) (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Alabama at Birmingham
Primary completion
Dec 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Patients Alive at 72 Hours After Episode.
230; 275
SECONDARY
Return of Spontaneous Circulation (ROSC)
361; 420
SECONDARY
Number of Patients Alive at Hospital Discharge
121; 163
SECONDARY
Number of Patients With Favorable Neurologic Status on Hospital Discharge
75; 107

Summary

The primary objective of the trial is to determine if 72-hour survival after out-of-hospital cardiac arrest (OHCA) is improved with initial endotracheal intubation (ETI) over initial laryngeal tube (LT) airway management strategies.

Eligibility Criteria

Inclusion Criteria

  • Out-of-hospital cardiac arrest (OHCA)
  • Adult (age ≥18 years or per local interpretation)
  • Non-traumatic etiology
  • Initiation of ventilatory support (e.g., bag-valve-mask device, non-rebreather mas, etc.)

Exclusion Criteria

  • Known pregnant women
  • Known prisoners
  • Major facial trauma (visible major deformity, copious oral bleeding, etc)
  • Major bleeding or exsanguination (e.g., major upper or lower GI bleed, visceral perforation, major uncontrolled bleeding from laceration or injury)
  • Patient receiving initial care by a non-PART participating EMS agency capable of performing ETI, LT, or other advanced airway management
  • Patients with ET tube, LT or other advanced airway device inserted prior to participating EMS agency arrival (e.g., inserted by healthcare facility personnel)
  • Patients with a pre-existing tracheostomy
  • Obvious asphyxial cardiac arrest (e.g., choking, foreign body aspiration, angioedema, epiglottitis, trauma to mouth and face, etc.)
  • Patients with a left ventricular assist device (LVAD) or total artificial heart (TAH)
  • Patients with pre-existing written "do-not-attempt-resuscitation" (DNAR) orders
  • Inter-facility transports
  • Patients with a "do not enroll" bracelet
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02419573). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search